AÑora, Maylen .

HRN: 28-90-53  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2026
CEFUROXIME 500MG (TAB)
04/25/2026
05/01/2026
PO
500MG
BID
Sp NSVD: Thinly MSaf
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: